SAM
Simplify Asset Management Portfolio holdings
AUM
$1.65B
This Quarter Return
+5.7%
1 Year Return
+8.73%
3 Year Return
+37.73%
5 Year Return
–
10 Year Return
–
AUM
$645M
AUM Growth
+$645M
(+6.3%)
Cap. Flow
-$3.89M
Cap. Flow
% of AUM
-0.6%
Top 10 Holdings %
Top 10 Hldgs %
78.23%
Holding
139
New
20
Increased
18
Reduced
42
Closed
23
Top Buys
| 1 |
Simplify Aggregate Bond ETF
AGGH
|
$49.1M |
| 2 |
Simplify Stable Income ETF
BUCK
|
$26.7M |
| 3 |
PIMCO 15+ Year US TIPS Index Exchange-Traded Fund
LTPZ
|
$10.9M |
| 4 |
Masimo
MASI
|
$4.33M |
| 5 |
Simplify MBS ETF
MTBA
|
$3.22M |
Top Sells
Sector Composition
| 1 | Healthcare | 14.77% |
| 2 | Energy | 3.39% |
| 3 | Technology | 0.78% |
| 4 | Financials | 0.75% |
| 5 | Real Estate | 0.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Quanterix
QTRX
$211M
| $604K | 0.05% |
22,101
-1,617
| -7% | -$44.2K |
|
77
iShares 0-5 Year Investment Grade Corporate Bond ETF
SLQD
$2.37B
| $598K | 0.05% |
12,148
-31,423
| -72% | -$1.55M |
|
78
Sutro Biopharma
STRO
$72.7M
| $515K | 0.05% |
120,000
| – | – |
|
79
NVIDIA
NVDA
$4.24T
| $511K | 0.05% |
1,032
+52
| +5% | +$25.8K |
|
80
Abbott
ABT
$231B
| $435K | 0.04% |
3,955
-288
| -7% | -$31.7K |
|
81
Amgen
AMGN
$155B
| $435K | 0.04% |
1,510
-12,029
| -89% | -$3.46M |
|
82
Tesla
TSLA
$1.08T
| $427K | 0.04% |
1,720
-178
| -9% | -$44.2K |
|
83
Microsoft
MSFT
$3.77T
| $396K | 0.04% |
1,053
+53
| +5% | +$19.9K |
|
|
CEE
84
Central and Eastern Europe Fund
CEE
$105M
| $380K | 0.03% |
38,957
| – | – |
|
85
X4 Pharmaceuticals
XFOR
$84.2M
| $335K | 0.03% |
400,000
| – | – |
|
86
Bio-Techne
TECH
$8.5B
| $329K | 0.03% |
4,264
-312
| -7% | -$24.1K |
|
87
ResMed
RMD
$40.2B
| $312K | 0.03% |
+1,812
| New | +$312K |
|
88
Establishment Labs
ESTA
$1.2B
| $307K | 0.03% |
11,863
-870
| -7% | -$22.5K |
|
|
ARR
89
Armour Residential REIT
ARR
$1.77B
| $290K | 0.03% |
+15,000
| New | +$290K |
|
90
SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
$2.78B
| $283K | 0.03% |
9,267
| – | – |
|
91
QuidelOrtho
QDEL
$1.95B
| $266K | 0.02% |
3,610
-264
| -7% | -$19.5K |
|
92
Cooper Companies
COO
$13.4B
| $263K | 0.02% |
696
-55
| -7% | -$20.8K |
|
93
Zoetis
ZTS
$69.3B
| $263K | 0.02% |
1,331
-96
| -7% | -$18.9K |
|
94
Syndax Pharmaceuticals
SNDX
$1.41B
| $255K | 0.02% |
11,801
-864
| -7% | -$18.7K |
|
95
ASML
ASML
$292B
| $238K | 0.02% |
315
-46
| -13% | -$34.8K |
|
96
Lantheus
LNTH
$3.73B
| $238K | 0.02% |
+3,838
| New | +$238K |
|
|
XYZ
97
Block, Inc.
XYZ
$48.5B
| $228K | 0.02% |
+2,947
| New | +$228K |
|
98
Lemonade
LMND
$3.91B
| $218K | 0.02% |
13,530
-2,948
| -18% | -$47.6K |
|
99
LivaNova
LIVN
$3.08B
| $207K | 0.02% |
4,007
-294
| -7% | -$15.2K |
|
|
CYBN
100
Cybin
CYBN
$176M
| $205K | 0.02% |
500,000
| – | – |
|